Literature DB >> 12529457

Ensuring safe and effective medical devices.

David W Feigal1, Susan N Gardner, Mark McClellan.   

Abstract

Mesh:

Year:  2003        PMID: 12529457     DOI: 10.1056/NEJMp020170

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

Review 1.  Endoscopic therapy for gastroesophageal reflux disease.

Authors:  Walter J Hogan
Journal:  Curr Gastroenterol Rep       Date:  2003-06

2.  Medical reversal: why we must raise the bar before adopting new technologies.

Authors:  Vinay Prasad; Adam Cifu
Journal:  Yale J Biol Med       Date:  2011-12

3.  FDA regulation of cardiovascular devices and opportunities for improvement.

Authors:  Sanket S Dhruva; Rita F Redberg
Journal:  J Interv Card Electrophysiol       Date:  2012-12-21       Impact factor: 1.900

4.  Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD.

Authors:  K Vonbank; R Ziesche; T W Higenbottam; L Stiebellehner; V Petkov; P Schenk; P Germann; L H Block
Journal:  Thorax       Date:  2003-04       Impact factor: 9.139

5.  Monitoring device safety in interventional cardiology.

Authors:  Michael E Matheny; Lucila Ohno-Machado; Frederic S Resnic
Journal:  J Am Med Inform Assoc       Date:  2005-12-15       Impact factor: 4.497

6.  Fidelity of ECT Devices : An alert to Clinicians.

Authors:  Chittaranjan Andrade
Journal:  Indian J Psychiatry       Date:  2003-10       Impact factor: 1.759

7.  New risks inadequately managed: the case of smart implants and medical device regulation.

Authors:  Shawn H E Harmon; Gill Haddow; Leah Gilman
Journal:  Law Innov Technol       Date:  2015

Review 8.  Who is responsible for evaluating the safety and effectiveness of medical devices? The role of independent technology assessment.

Authors:  Mitchell D Feldman; Amy J Petersen; Leah S Karliner; Jeffrey A Tice
Journal:  J Gen Intern Med       Date:  2008-01       Impact factor: 5.128

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.